Nalaganje...

FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells

Cancer initiating cells (CICs) drive tumor formation and drug-resistance, but how they develop drug-resistance characteristics is not well understood. In this study, we demonstrate that chemotherapeutic agent FOLFOX, commonly used for drug-resistant/metastatic colorectal cancer (CRC) treatment, indu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Sci
Main Authors: Ghatak, Shibnath, Hascall, Vincent C., Markwald, Roger R., Misra, Suniti
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7828641/
https://ncbi.nlm.nih.gov/pubmed/33451103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22020753
Oznake: Označite
Brez oznak, prvi označite!